Spyre Therapeutics Plunges; Why Analysts Aren't Sweating
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Expedia Executive Sells 3,133 Shares for $1 Million
An Expedia insider disposed of more than 3,000 shares after a strong 12-month run for the stock price.
US takes down alleged Chinese hacking tools used against Federal Reserve, DOJ and Senate
The DOJ said it disrupted Chinese state-backed tools used to scan, infect and exploit IoT devices for attacks on federal agencies and multiple industries.
Will Bloom Energy Be the Next SpaceX? What the Numbers Actually Say.
Key PointsBloom Energy’s stock skyrocketed over the past two years.
1 Wall Street Analyst Just Upgraded AMD Stock and Estimates 30% Upside. Here's Why He's Bullish on This Semiconductor Stock.
AMD is riding the next wave of AI chip demand.
Real move in mining stocks just beginning, veteran market analyst says
Founder of Momentum Structural Analysis asserts the gold and silver rally signals the start of a big move in mining and metals stocks.
Dow Jones Industrial Average ignores a revision made of inflation
The Dow Jones Industrial Average trades a shade beneath 53,500 and roughly 100 points lower on the session, after a 12:30 GMT data drop the wires filed as uneventful.